Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Sept 2023 for 180 Life Sciences Corp., €27k. Read the official filing
Filing timeline
BuySaleRussell T. Ray
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Russell T. Ray: trading record in brief
This profile gathers the share dealings of Russell T. Ray across 2 companies, led by FORUM MARKETS Inc and Merrimack Pharmaceuticals Inc. Over a trading history stretching from 31 December 2021 to 4 September 2023, the count stands at 7 filings.
Every open-market trade on record is a sale: 1 sale worth €3,391. Outside the open market, there are 6 share grants.
Most recently, on 8 September 2023, the filings show a share grant worth €27k in FORUM MARKETS Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Russell T. Ray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
21,455 shares@ US$1.3634.1% of flowCommon StockSEC:0001213900-23-075377:0
30,702 shares0Common StockSEC:0001213900-22-068720:0
13,068 shares0Common StockSEC:0001213900-22-042959:0
10,570 shares@ US$1.3617.1% of flowCommon StockSEC:0001213900-22-042957:0
10,570 shares@ US$1.3625.6% of flowCommon StockSEC:0001213900-22-028982:0
4,728 shares@ US$3.0423.6% of flowCommon StockSEC:0001213900-22-002425:0
1,000 shares@ US$3.8398100.0% of flowCommon StockSEC:0000899243-22-000473:0
7 of 7 declarations
